Indivior Pharmaceuticals, Inc. Common Stock

INDVNASDAQ • USD
34.41 USD
↘ 0.15 (0.43%)🟢PRE MARKET (AS OF 07:49 AM EDT)
🟢Market: OPEN

INDV is currently priced at $34.41. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bearish long-term moving average alignment. On the valuation side, INDV appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 26, 2026.

Open?$34.61
High?$34.86
Low?$34.29
Prev. Close?$34.56
Volume?243
Avg. Volume?2.4M
VWAP?$34.66
Rel. Volume?0.00x
Bid / Ask
Bid?$34.42 × 200
Ask?$34.69 × 200
Spread?$0.27
Midpoint?$34.56
Valuation & Ratios
Market Cap?4.1B
Shares Out?N/A
Float?116.6M
Float %?98.8%
P/E Ratio?11.49
P/B Ratio?-19.61
EPS?$3.01
Dividend?0.00%
Ex-Dividend?2026-11-03
News
Profile
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Employees
838
Market Cap
4.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-12-24
Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
81
Momentum?
88
Short Sent.?
45
Piotroski F-Score?0/9Weak
Altman Z-Score?3.38Safe
Confidence?49%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.08%Elevated
Short Interest?9.4M
Days to Cover?3.4
Free Float116.6M
Avg Daily Volume2.8M
Settlement Date2026-10-15
Financial Health
Current Ratio?0.84Weak
Quick Ratio?0.66Weak
Cash Ratio?0.26Low
Debt/Equity?-2.34Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
87/100
P/E?
Peers
100
S&P
92
11.5CHEAP▾
P/B?
S&P
97
-19.61CHEAP▾
P/S?
Peers
100
S&P
50
3.06FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
81
10.1CHEAP▾
EV/Sales?
Peers
100
S&P
57
3.26FAIR▾
Returns & Efficiency
ROE?
S&P
3
-170.7%WEAK▾
ROA?
Peers
50
S&P
97
28.8%STRONG▾
Cash Flow & Enterprise
FCF?$-111000000
Enterprise Value?$4.3B
Fundamentals ratios updated end of day